Correlation Between PDS Biotechnology and Dynex Capital

Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Dynex Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Dynex Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PDS Biotechnology Corp and Dynex Capital, you can compare the effects of market volatilities on PDS Biotechnology and Dynex Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Dynex Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Dynex Capital.

Diversification Opportunities for PDS Biotechnology and Dynex Capital

-0.88

Correlation Coefficient

PDS Biotechnology  Dynex Capital

Pay attention - limited upside

The 3 months correlation between PDS and Dynex is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Dynex Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynex Capital and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Dynex Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynex Capital has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Dynex Capital go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Dynex Capital

Assuming the 90 days horizon PDS Biotechnology Corp is expected to under-perform the Dynex Capital. In addition to that, PDS Biotechnology is 3.09 times more volatile than Dynex Capital. It trades about -0.04 of its total potential returns per unit of risk. Dynex Capital is currently generating about 0.03 per unit of volatility. If you would invest  977.00  in Dynex Capital on October 26, 2024 and sell it today you would earn a total of  223.00  from holding Dynex Capital or generate 22.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

PDS Biotechnology Corp  vs.  Dynex Capital

PDS Biotechnology Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Dynex Capital

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dynex Capital are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Dynex Capital may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with PDS Biotechnology and Dynex Capital

The main advantage of trading using opposite PDS Biotechnology and Dynex Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Dynex Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynex Capital will offset losses from the drop in Dynex Capital's long position.

The idea behind PDS Biotechnology Corp and Dynex Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.